TY - JOUR
T1 - Seleno-L-methionine protects against β-amyloid and iron/hydrogen peroxide-mediated neuron death
AU - Xiong, Shuling
AU - Markesbery, William R.
AU - Shao, Changxing
AU - Lovell, Mark A.
PY - 2007/4
Y1 - 2007/4
N2 - Increasing evidence suggests a role for oxidative stress in several neurodegenerative diseases, including Alzheimer's disease (AD), and that selenium compounds may function as antioxidants. To evaluate the antioxidant mechanism of selenium, primary rat hippocampal neurons were pretreated with seleno-L-methionine (SeMet) for 16 h prior to treatment with iron/hydrogen peroxide (Fe2+/H2O2) or amyloid beta peptide (Aβ25-35); free radical generation was assessed using laser confocal microscopy and CM-H2DCFDA and APF. Treatment with Fe 2+/H2O2 or Aβ significantly decreased cell survival and increased free radical generation compared to cultures treated with vehicle alone. In contrast, cultures pretreated with SeMet showed significantly (p < 0.05) increased survival and significantly lower CM-H 2DCFDA and APF fluorescence compared to Fe2+/H 2O2 or Aβ treated cultures. To determine if SeMet protection was mediated by glutathione peroxidase (GPx), levels of GPx protein and activity were measured using confocal microscopy and a selenium-dependent GPx specific antibody and an activity assay. Pretreatment with SeMet significantly (p < 0.05) increased GPx protein and activity in Fe 2+/H2O2- and Aβ-treated cultures compared to cultures treated with Fe2+/H2O2 or Aβ alone. These data suggest that SeMet can decrease free radical generation induced by Fe2+/H2O2 or Aβ through modulation of GPx and may be suitable as a potential therapeutic agent in neurodegenerative diseases where there is increased oxidative stress.
AB - Increasing evidence suggests a role for oxidative stress in several neurodegenerative diseases, including Alzheimer's disease (AD), and that selenium compounds may function as antioxidants. To evaluate the antioxidant mechanism of selenium, primary rat hippocampal neurons were pretreated with seleno-L-methionine (SeMet) for 16 h prior to treatment with iron/hydrogen peroxide (Fe2+/H2O2) or amyloid beta peptide (Aβ25-35); free radical generation was assessed using laser confocal microscopy and CM-H2DCFDA and APF. Treatment with Fe 2+/H2O2 or Aβ significantly decreased cell survival and increased free radical generation compared to cultures treated with vehicle alone. In contrast, cultures pretreated with SeMet showed significantly (p < 0.05) increased survival and significantly lower CM-H 2DCFDA and APF fluorescence compared to Fe2+/H 2O2 or Aβ treated cultures. To determine if SeMet protection was mediated by glutathione peroxidase (GPx), levels of GPx protein and activity were measured using confocal microscopy and a selenium-dependent GPx specific antibody and an activity assay. Pretreatment with SeMet significantly (p < 0.05) increased GPx protein and activity in Fe 2+/H2O2- and Aβ-treated cultures compared to cultures treated with Fe2+/H2O2 or Aβ alone. These data suggest that SeMet can decrease free radical generation induced by Fe2+/H2O2 or Aβ through modulation of GPx and may be suitable as a potential therapeutic agent in neurodegenerative diseases where there is increased oxidative stress.
UR - http://www.scopus.com/inward/record.url?scp=33847204338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847204338&partnerID=8YFLogxK
U2 - 10.1089/ars.2006.1363
DO - 10.1089/ars.2006.1363
M3 - Article
C2 - 17280487
AN - SCOPUS:33847204338
SN - 1523-0864
VL - 9
SP - 457
EP - 467
JO - Antioxidants and Redox Signaling
JF - Antioxidants and Redox Signaling
IS - 4
ER -